Broadcom stock price steadies after early dip as Citi trims AVGO target, AI chip bets stay twitchy

Broadcom stock price steadies after early dip as Citi trims AVGO target, AI chip bets stay twitchy

February 18, 2026

NEW YORK, Feb 18, 2026, 10:50 (ET) — Regular session

Shares of Broadcom Inc (AVGO.O) edged up 0.6% to $334.56 during Wednesday morning trading. Earlier in the session, the stock bounced from as low as $326.68 to as high as $336.25. The chipmaker remains caught in the churn that’s hit AI-related stocks lately.

Why does that matter? Investors have been using Broadcom as a bellwether for the custom-chip spending spree among major cloud players, eyeing what it means for profitability. Broadcom’s specialty: custom ASICs — those application-specific integrated circuits tailor-made for single tasks — plus the networking silicon that links up AI servers. In December, management flagged that gross margins might slip as the AI part of the business ramps, though they highlighted a hefty $73 billion backlog.

Macro factors are back in play. Investors are watching for the Federal Reserve’s January meeting minutes, expected at 2 p.m. EST. Fed Chair Jerome Powell, after that meeting, said “upside risks to inflation” and “downside risks to employment” had “diminished a bit”—language that has the potential to shift rate expectations and ripple through pricey tech shares. Reuters

Nvidia announced a multiyear agreement to provide Meta Platforms with millions of AI chips—this covers both the current Blackwell line and the next-gen Rubin processors, plus Grace and Vera CPUs. Meta isn’t just buying hardware; it’s developing its own AI chips, too, and is reportedly in discussions with Google regarding access to Tensor Processing Units, or TPUs, according to Reuters.

A new analyst note stirred things up again. Citigroup’s Atif Malik lowered his price target on Broadcom to $458 from $480 but stuck with his Buy rating. He argued that concerns around gross margins, TPU competition and software sales risks are “mostly priced into” the stock. TipRanks

Broadcom’s VMware software business still stands out as a separate point for investors. According to CloudBolt, a January poll of 302 large North American companies showed 86% are cutting back on VMware use, and 88% worry about price hikes ahead. “The panic phase is over. Now it’s execution,” CloudBolt CEO Rod Squires said. GlobeNewswire

Selective buying popped up, too. Cathie Wood’s ARK funds picked up 24,205 Broadcom shares—roughly $7.87 million worth—during Tuesday’s session, a daily trades recap from Investing.com showed.

Broadcom pushed higher while U.S. indexes ticked up, tech stocks regaining some ground. Traders eyed upcoming Fed minutes and inflation numbers due this week. Nvidia rallied on news of its Meta supply agreement, which gave a boost to several semiconductor names.

The risks are straightforward. Should customers push further toward Nvidia-focused setups, or if Broadcom’s margins shrink beyond what investors have priced in, shares could stumble fast. VMware renewal rates and how quickly clients migrate still hang in the balance, adding another layer of doubt.

Broadcom is set to report quarterly results after the bell on March 4, with its conference call kicking off at 5 p.m. ET. Market watchers want clarity on AI order trends, margins, and any signs that VMware churn might be stabilizing.

Marcin Frąckiewicz

Marcin Frąckiewicz is the CEO of TS2 Space and a longtime technology entrepreneur focused on telecommunications, satellite communications and digital innovation. A graduate of the Warsaw School of Economics (SGH), he writes about space technology, artificial intelligence and publicly traded technology companies. His analysis covers major market trends, emerging technologies and the businesses shaping the future of the global economy.

Stock Market Today

  • A2 Milk (ASX:A2M) falls 24.3% in 2025 as investors weigh outlook
    July 26, 2026, 12:02 AM EDT. A2 Milk Company Ltd (ASX:A2M) shares have tumbled 24.3% since early 2025 as investors look closer at the business. Based in New Zealand, A2M sells dairy products with the A2-only protein type, marketed as easier to digest than A1. The company outsources much of its production and has a key supply deal with Synlait Milk for making infant formula. Consumer staples names like A2M are known for resilience and less volatility in slower economies but A2M's dividend yield is still just 0.28% over five years-pointing to some company-specific risks. The price-to-sales ratio is at 4.01 now, higher than its five-year average of 3.44, signaling a premium even with falling shares. Investors are weighing A2M's growth narrative against the sector, with the ASX Consumer Staples Index lagging the wider market.